A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
Kang, Y-K, Rha, S Y, Tassone, P, Barriuso, J, Yu, R, Szado, T, Garg, A, Bang, Y-JVolume:
111
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2014.356
Date:
August, 2014
File:
PDF, 400 KB
english, 2014